Last reviewed · How we verify

NCT04942366

High-Intensity Interval Training On Women With Polycystic Ovary Syndrome.

Completed NA Results posted Last updated 2 February 2024
What this trial tests

NA trial testing High intensity interval training in Polycystic Ovary Syndrome in 50 participants. Completed in 15 December 2021.

Timeline
12 April 2021
Primary endpoint
15 December 2021
15 December 2021

Quick facts

Lead sponsorZiauddin University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment50
Start date12 April 2021
Primary completion15 December 2021
Estimated completion15 December 2021
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Ziauddin University

Who can join

Adults 20 to 40, female only, with Polycystic Ovary Syndrome. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Serum Testosterone Primary · 0 weeks to 12-weeks

Levels of serum testosterone

0-week
GroupValue95% CI
HIIT Group2.54± 0.07
ST Group2.54± 0.09
12-weeks
GroupValue95% CI
HIIT Group2.39± 0.14
ST Group2.47± 0.09
Body Fat Percentage Primary · 0-week to 12-weeks

Using skinfold method (body caliper)

0-week
GroupValue95% CI
HIIT Group31.59± 1.79
ST Group34.12± 2.69
12-weeks
GroupValue95% CI
HIIT Group29.62± 1.76
ST Group32.48± 2.87
Physical Activity Primary · 0-week to 12-weeks

International physical activity questionnaire

0-week
GroupValue95% CI
HIIT Group3491.15± 211.99
ST Group3439.60± 243.76
12-weeks
GroupValue95% CI
HIIT Group3928.10± 220.04
ST Group3716.60± 234.45

Sponsor's own description

This RCT is aimed towards determining the effectiveness of exercises based intervention strategy involving high intensity interval training exercises in improving serum testosterone level, body fat composition and physical activity in hopes to provide a definitive exercise regime for the ever common symptoms of pcos. It will be based on the theory that exercise helps in decreasing testosterone level that in turn decrease high androgen levels in the body, exercise further decreases body fat composition (obesity is a common cause or manifestation of pcos).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of High intensity interval training

Trials testing the same drug.

Other recruiting trials for Polycystic Ovary Syndrome

Currently open trials in the same condition.

Other Ziauddin University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04942366.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing